4th Quarter - Report — CEPHALON, INC. for CEPHALON INC (2008)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

CEPHALON, INC.

Client

CEPHALON INC

Income

—

Expenses

$441,146

Expense method

C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
4th Quarter - Report (this page)	Jan 21, 2009	$441,146	Replaced
4th Quarter - Amendment	Jun 18, 2010	$441,146	Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Brazillian intellectual property issues

Lobbyist	Covered position, as disclosed
JEFF M MYERS	—

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); Commerce, Dept of (DOC); SENATE; Executive Office of the President (EOP); Drug Enforcement Administration (DEA); Veterans Affairs, Dept of (VA); Natl Institute on Alcohol Abuse & Alcoholism (NIAA); Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); State, Dept of (DOS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH)

Copyright/Patent/Trademark CPT

H.R. 1908-Patent Reform Act, provisions related to pharmaceutical patents H.R. 1432-Preserve Access to Affordable Generics Act, to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market

Lobbyist	Covered position, as disclosed
JEFF M MYERS	—

Contacted: State, Dept of (DOS); Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); Executive Office of the President (EOP); Natl Institute on Alcohol Abuse & Alcoholism (NIAA); Centers For Medicare and Medicaid Services (CMS); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ)

Bills named: H.R. 1908 (110th), H.R. 1432 (110th)

Budget/Appropriations BUD

Support for additional FDA resources. Support for SAMHSA funding. HHS Education Appropriations.

Lobbyist	Covered position, as disclosed
JEFF M MYERS	—

Contacted: Natl Institutes of Health (NIH); Federal Trade Commission (FTC); Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Natl Institute on Alcohol Abuse & Alcoholism (NIAA); State, Dept of (DOS); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA)

Alcohol and Drug Abuse ALC

Access and reimbursement issues regarding Alcohol pharmacotherapies. H.R. 1424/S. 558 - Paul Wellstone Mental Health and Addiction Equity Act of 2007, parity related issues. Departments of Labor, Health & Human Services, and Education, and Related Agencies Appropriations Act, FY 2009, addiction treatment issues. Military Construction and Veterans Affairs Appropriations Act, FY 2009, veterans access to addiction treatment issues.

Lobbyist	Covered position, as disclosed
JEFF M MYERS	—

Contacted: Food & Drug Administration (FDA); Substance Abuse & Mental Health Services Administration (SAMHSA); Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); SENATE; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Federal Trade Commission (FTC); Veterans Affairs, Dept of (VA); Commerce, Dept of (DOC); Natl Institutes of Health (NIH); Natl Institute on Alcohol Abuse & Alcoholism (NIAA)

Bills named: H.R. 1424 (110th), S. 558 (110th)

Health Issues HCR

S.2029-Physician Payments Sunshine Act of 2007 H.R.5613-Protecting the Medicaid Safety Net Act H.R.3610-Food & Drug Import Safety Act H.R.4-Medicare Prescription Drug Price Negotiation Act of 2007 Comparative Effectiveness in H.R.3162

Lobbyist	Covered position, as disclosed
JEFF M MYERS	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Natl Institute on Alcohol Abuse & Alcoholism (NIAA); Federal Trade Commission (FTC); Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Justice, Dept of (DOJ); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Natl Institutes of Health (NIH); Drug Enforcement Administration (DEA); State, Dept of (DOS)

Bills named: H.R. 3162 (110th), H.R. 4 (110th), S. 2029 (110th), H.R. 5613 (110th), H.R. 3610 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.